Outlook Therapeutics
OTLK
#8584
Rank
โ‚น10.25 B
Marketcap
โ‚น433.36
Share price
-2.84%
Change (1 day)
-39.54%
Change (1 year)

Earnings for Outlook Therapeutics (OTLK)

Earnings in 2024 (TTM): -โ‚น7.84 Billion

According to Outlook Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚น4.36 Billion, an increase over its 2022 earnings that were of -โ‚น5.94 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Outlook Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น7.84 Billion80.19%
2023 -โ‚น4.36 Billion-26.7%
2022 -โ‚น5.94 Billion32.13%
2021 -โ‚น4.5 Billion46.21%
2020 -โ‚น3.08 Billion-18.82%
2019 -โ‚น3.79 Billion16.62%
2018 -โ‚น3.25 Billion57.88%
2017 -โ‚น2.06 Billion-56.17%
2016 -โ‚น4.69 Billion-9.26%
2015 -โ‚น5.17 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น9.67 Billion 21.71% Jersey
-โ‚น23.12 Billion 190.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น1.19 Billion-85.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น6.18 Billion-22.31%๐Ÿ‡ฌ๐Ÿ‡ง UK